Narui K, Miura D, Hasegawa Y, Tachibana A, et al. A Randomized Controlled Phase 2 Study of Neoadjuvant Eribulin Versus Paclitaxel in Women with Operable Breast Cancer: The JONIE-3 Study. Clin Breast Cancer 2022 Aug 22. pii: S1526-8209(22)00184.
PMID: 36151017